Pfizer competitorsClear all

Bausch Health's top competitors include Astellas Pharma, Boehringer Ingelheim, Merck Group, Sanofi, Takeda Pharmaceutical, Amgen, Merck, Bristol-Myers Squibb, Bayer, GSK and Eli Lilly.
Bausch Health
Bausch Health
Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products.
Astellas Pharma
Astellas Pharma
Astellas Pharma is a pharmaceutical company focused on the development of drugs and medical solutions.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses.
Merck Group
Merck Group
Merck Group is a pharmaceutical, chemical, and life sciences company.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Takeda Pharmaceutical
Takeda Pharmaceutical
Takeda Pharmaceutical is a biopharmaceutical company.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Merck
Merck
Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with serious and life-threatening diseases.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and nutrition.
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company.
Eli Lilly
Eli Lilly
Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products.
Founding Date
Founding Date
1959
Founding Date
1923
Founding Date
1885
Founding Date
1668
Founding Date
2004
Founding Date
1781
Founding Date
1980
Founding Date
1891
Founding Date
1887
Founding Date
1863
Founding Date
2000
Founding Date
1876
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Laval, CA HQ
Buenos Aires, AR
Wien, AT
Sarajevo, BA
Indaiatuba, BR
Porto Alegre, BR
Sao Paulo, BR
see more
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
Ingelheim am Rhein, DE HQ
Algiers, DZ
Munro, AR
Macquarie Park, AU
Vienna, AT
Minsk, BY
Elsene, BE
see more
Locations
Darmstadt, DE HQ
Hydra, DZ
Csd, AR
Bayswater, AU
Bayswater, AU
Macquarie Park, AU
Wien, AT
see more
Locations
Paris, FR HQ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
Zaventem, BE
see more
Locations
Tokyo, JP HQ
The Rocks, AU
Linz, AT
Wien, AT
Sint Jans Molenbeek, BE
Santo Amaro, BR
Toronto, CA
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Machelen, BE
see more
Locations
Kenilworth, US HQ
Hydra, DZ
Munro, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
Manama, BH
see more
Locations
New York, US HQ
Braine L'alleud, BE
Watermaal Bosvoorde, BE
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
see more
Locations
Leverkusen, DE HQ
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
Dhaka, BD
see more
Locations
Brentford, GB HQ
Boudouaou, DZ
San Fernando, AR
Abbotsford, AU
Boronia, AU
Ermington, AU
Wien, AT
see more
Locations
Indianapolis, US HQ
Melrose Park, AU
Wien, AT
Brussel, BE
São Paulo, BR
Toronto, CA
Las Condes, CL
see more
Employees
Employees
21,7003% increase
Employees
15,8832% decrease
Employees
51,0151% increase
Employees
58,1272% increase
Employees
100,4094% decrease
Employees
47,4954% decrease
Employees
23,4009% increase
Employees
71,0003% increase
Employees
30,00029% increase
Employees
101,1683% decrease
Employees
99,4374% increase
Employees
33,62513% decrease
Valuation ($)
Valuation ($)
11.2 b
Valuation ($)
27.9 b
Valuation ($)
N/A
Valuation ($)
76.7 b
Valuation ($)
130.6 b
Valuation ($)
52.4 b
Valuation ($)
141 b
Valuation ($)
199.7 b
Valuation ($)
141.8 b
Valuation ($)
63.8 b
Valuation ($)
93.3 b
Valuation ($)
178.3 b
Twitter followers
Twitter followers
560
Twitter followers
50.4 k
Twitter followers
101.4 k
Twitter followers
20.6 k
Twitter followers
140.9 k
Twitter followers
N/A
Twitter followers
99.4 k
Twitter followers
208 k
Twitter followers
151.8 k
Twitter followers
179.2 k
Twitter followers
222.6 k
Twitter followers
130.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
54
Number of tweets (last 30 days)
97
Number of tweets (last 30 days)
42
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
77
Number of tweets (last 30 days)
33
Number of tweets (last 30 days)
61
Number of tweets (last 30 days)
183
Number of tweets (last 30 days)
69
Number of tweets (last 30 days)
87
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
9.8
Average likes per tweet (last 30 days)
4.9
Average likes per tweet (last 30 days)
24.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
8.8
Average likes per tweet (last 30 days)
24.2
Average likes per tweet (last 30 days)
8.7
Average likes per tweet (last 30 days)
3.4
Average likes per tweet (last 30 days)
15.4
Average likes per tweet (last 30 days)
4.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
96%
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
89.69%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
98.7%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
43.72%
Percentage of tweets with engagement (last 30 days)
91.3%
Percentage of tweets with engagement (last 30 days)
58.62%
Alexa Website Rank
Alexa Website Rank
261814
Alexa Website Rank
270550
Alexa Website Rank
192222
Alexa Website Rank
150790
Alexa Website Rank
123373
Alexa Website Rank
155239
Alexa Website Rank
200877
Alexa Website Rank
56943
Alexa Website Rank
101235
Alexa Website Rank
85997
Alexa Website Rank
58088
Alexa Website Rank
108463
Employee Rating
Employee Rating
2.8
Employee Rating
3.1
Employee Rating
4.1
Employee Rating
4
Employee Rating
3.3
Employee Rating
N/A
Employee Rating
4
Employee Rating
4.2
Employee Rating
4.1
Employee Rating
N/A
Employee Rating
3.8
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
$8b (FY, 2020)
Revenue (est.)
¥1.3t (FY, 2020)
Revenue (est.)
€21.3b (FY, 2019)
Revenue (est.)
€17.5b (FY, 2020)
Revenue (est.)
(€926m) (FY, 2020)
Revenue (est.)
¥3.3t (FY, 2020)
Revenue (est.)
$25.4b (FY, 2020)
Revenue (est.)
$48b (FY, 2020)
Revenue (est.)
$42.5b (FY, 2020)
Revenue (est.)
€43.5b (FY, 2019)
Revenue (est.)
£33.8b (FY, 2019)
Revenue (est.)
$24.5b (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
¥276.7b (FY, 2020)
Cost of goods
€7.3b (FY, 2019)
Cost of goods
€6.8b (FY, 2020)
Cost of goods
€12.2b (FY, 2020)
Cost of goods
¥1.1t (FY, 2020)
Cost of goods
$6.2b (FY, 2020)
Cost of goods
$15.5b (FY, 2020)
Cost of goods
$11.8b (FY, 2020)
Cost of goods
€17.5b (FY, 2019)
Cost of goods
£11.9b (FY, 2019)
Cost of goods
$5.5b (FY, 2020)
Gross profit
Gross profit
N/A
Gross profit
¥1t (FY, 2020)
Gross profit
€14b (FY, 2019)
Gross profit
€10.7b (FY, 2020)
Gross profit
(€13.1b) (FY, 2020)
Gross profit
¥2.2t (FY, 2020)
Gross profit
$19.3b (FY, 2020)
Gross profit
$32.5b (FY, 2020)
Gross profit
$30.7b (FY, 2020)
Gross profit
€26.1b (FY, 2019)
Gross profit
£21.9b (FY, 2019)
Gross profit
$19.1b (FY, 2020)
Net income
Net income
($559m) (FY, 2020)
Net income
¥195.4b (FY, 2020)
Net income
€2.7b (FY, 2019)
Net income
€2b (FY, 2020)
Net income
€12.4b (FY, 2020)
Net income
¥44.3b (FY, 2020)
Net income
$7.3b (FY, 2020)
Net income
$7.1b (FY, 2020)
Net income
($9b) (FY, 2020)
Net income
€2.4b (FY, 2019)
Net income
£5.3b (FY, 2019)
Net income
$6.2b (FY, 2020)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
66 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
100 (FY, 2019)
Countries
N/A
Countries
N/A
Countries
153 (FY, 2018)
Countries
N/A
Countries
120 (FY, 2019)
Manufacturing Facilities
Manufacturing Facilities
37 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
7 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
87 (FY, 2016)
Manufacturing Facilities
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
34 (FY, 2019)
Patents (US)
1 (Nov, 2020)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
22 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
12 (FY, 2019)
Phase I Trials Products
27 (FY, 2019)
Phase I Trials Products (Immunology)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
1 (Oct, 2020)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
5 (FY, 2019)
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Immunology)
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
1 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
12 (FY, 2020)
Phase I Trials Products (Oncology)
1 (Jul, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
19 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Rare Diseases)
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
1 (FY, 2020)
Phase I Trials Products (Rare Diseases)
1 (Oct, 2019)
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase I Trials Products (Rare Diseases)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2019)
Phase II Trials Products
32 (Nov, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
12 (Jan, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
9 (FY, 2019)
Phase II Trials Products (Immunology)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
1 (Oct, 2020)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
4 (FY, 2019)
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Immunology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
1 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
6 (FY, 2020)
Phase II Trials Products (Oncology)
8 (Oct, 2019)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
14 (FY, 2019)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
14 (Feb, 2020)
Phase III Trials Products
25 (Nov, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
9 (Jan, 2020)
Phase III Trials Products
14 (FY, 2019)
Phase III Trials Products
15 (FY, 2019)
Phase III Trials Products (Immunology)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
1 (Oct, 2020)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
4 (FY, 2019)
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Immunology)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
4 (Oct, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
5 (Oct, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
9 (FY, 2019)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Products
Products
1.4 k (FY, 2019)
Products
N/A
Products
N/A
Products
300 k (FY, 2020)
Products
N/A
Products
N/A
Products
N/A
Products
102 (Nov, 2020)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
225 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
10 (May, 2018)
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
66 (FY, 2016)
Research and Development Centers
Research and Development Centers
23 (FY, 2019)
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
12 (FY, 2019)
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
68 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
86.4 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 310m
Total funding raised
$ 57.8m
Total funding raised
$ 175.5m
Total funding raised
$ 5.6m
Total funding raised
$ 15.5m
Total funding raised
$ 3.5b
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Astellas Pharma
HQ
Tokyo, JP
Employees
15,883↓ 2% decrease

Astellas Pharma is a pharmaceutical company focused on the development of drugs and medical solutions.

View company
Boehringer Ingelheim
HQ
Ingelheim am Rhein, DE
Employees
51,015↑ 1% increase

Boehringer Ingelheim a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses.

View company
Merck Group
HQ
Darmstadt, DE
Employees
58,127↑ 2% increase

Merck Group is a pharmaceutical, chemical, and life sciences company.

View company
Sanofi
HQ
Paris, FR
Employees
100,409↓ 4% decrease

Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.

View company